Bortezomib for Treating Glomerular Diseases

Clinical trial NCT05383547 · UNKNOWN

Trial details

NCT number: NCT05383547
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Bortezomib Glomerulonephritis MN MPGN FSGS IgA Nephropathy

Start date: 2022-08-02
Primary completion: 2023-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.